PL361118A1 - Suszony sublimacyjnie preparat pantoprazolu i zastrzyk pantoprazolu - Google Patents

Suszony sublimacyjnie preparat pantoprazolu i zastrzyk pantoprazolu

Info

Publication number
PL361118A1
PL361118A1 PL01361118A PL36111801A PL361118A1 PL 361118 A1 PL361118 A1 PL 361118A1 PL 01361118 A PL01361118 A PL 01361118A PL 36111801 A PL36111801 A PL 36111801A PL 361118 A1 PL361118 A1 PL 361118A1
Authority
PL
Poland
Prior art keywords
pantoprazole
freeze
dried
preparation
injection
Prior art date
Application number
PL01361118A
Other languages
English (en)
Other versions
PL201188B1 (pl
Inventor
Rango Dietrich
Rudolf Linder
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8170452&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL361118(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of PL361118A1 publication Critical patent/PL361118A1/pl
Publication of PL201188B1 publication Critical patent/PL201188B1/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL361118A 2000-11-22 2001-11-17 Sposób wytwarzania suszonego sublimacyjnie preparatu zawierającego 5-difluorometoksy-2-[(3,4-dimetoksy-2-pirydynylo)metylosulfinylo]-1H-benzimidazol (pantoprazol), jego sól, solwat pantoprazolu lub jego sól, liofilizowany preparat pantoprazolu otrzymany tym sposobem, preparat do iniekcji oraz zestaw zawierający preparat liofilizowany PL201188B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00125569 2000-11-22
PCT/EP2001/013296 WO2002041919A1 (en) 2000-11-22 2001-11-17 Freeze-dried pantoprazole preparation and pantoprazole injection

Publications (2)

Publication Number Publication Date
PL361118A1 true PL361118A1 (pl) 2004-09-20
PL201188B1 PL201188B1 (pl) 2009-03-31

Family

ID=8170452

Family Applications (1)

Application Number Title Priority Date Filing Date
PL361118A PL201188B1 (pl) 2000-11-22 2001-11-17 Sposób wytwarzania suszonego sublimacyjnie preparatu zawierającego 5-difluorometoksy-2-[(3,4-dimetoksy-2-pirydynylo)metylosulfinylo]-1H-benzimidazol (pantoprazol), jego sól, solwat pantoprazolu lub jego sól, liofilizowany preparat pantoprazolu otrzymany tym sposobem, preparat do iniekcji oraz zestaw zawierający preparat liofilizowany

Country Status (40)

Country Link
US (3) US6780881B2 (pl)
EP (2) EP1339430B1 (pl)
JP (1) JP4886158B2 (pl)
KR (2) KR100910607B1 (pl)
CN (1) CN1250292C (pl)
AR (2) AR034277A1 (pl)
AT (1) ATE381946T1 (pl)
AU (2) AU2002216042B2 (pl)
BG (1) BG66329B1 (pl)
BR (1) BRPI0115483B8 (pl)
CA (2) CA2428870C (pl)
CY (1) CY1107896T1 (pl)
CZ (1) CZ304348B6 (pl)
DE (1) DE60132108T2 (pl)
DK (1) DK1339430T3 (pl)
EA (1) EA007602B1 (pl)
EC (1) ECSP034613A (pl)
EE (1) EE05236B1 (pl)
ES (1) ES2298295T3 (pl)
GE (1) GEP20053461B (pl)
HK (1) HK1060848A1 (pl)
HR (1) HRP20030410B1 (pl)
HU (1) HUP0303278A3 (pl)
IL (2) IL155601A0 (pl)
IS (1) IS2971B (pl)
ME (1) ME00556B (pl)
MX (1) MXPA03004548A (pl)
MY (1) MY137726A (pl)
NO (1) NO332937B1 (pl)
NZ (1) NZ525911A (pl)
PE (1) PE20020582A1 (pl)
PL (1) PL201188B1 (pl)
PT (1) PT1339430E (pl)
RS (1) RS52024B (pl)
SI (1) SI1339430T1 (pl)
SK (1) SK287993B6 (pl)
TW (1) TWI284041B (pl)
UA (1) UA80961C2 (pl)
WO (1) WO2002041919A1 (pl)
ZA (1) ZA200303593B (pl)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY137726A (en) * 2000-11-22 2009-03-31 Nycomed Gmbh Freeze-dried pantoprazole preparation and pantoprazole injection
US20050287231A1 (en) * 2002-06-21 2005-12-29 Nussen Kenneth H Method and apparatus for oral hygiene products with green tea extract
KR20050071611A (ko) * 2002-10-25 2005-07-07 화이자 프로덕츠 인코포레이티드 현탁액 형태의 아릴헤테로환 활성제의 저장 제형
AU2003241150A1 (en) * 2003-05-06 2004-11-26 Hetero Drugs Limited Novel polymorphs of pantoprazole sodium
CL2004000983A1 (es) * 2003-05-08 2005-03-04 Altana Pharma Ag Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
CN1791406A (zh) * 2003-05-19 2006-06-21 普利瓦研究与发展有限公司 5-(二氟甲氧基)-2-[[(3,4-二甲氧基-2-吡啶基)甲基]亚硫酰基]-1h-苯并咪唑(泮托拉唑)钠水络合物的固态形式
AR045258A1 (es) * 2003-08-21 2005-10-19 Altana Pharma Ag Un producto farmaceutico para inyeccion
WO2005070426A1 (en) * 2004-01-27 2005-08-04 Altana Pharma Ag Freeze-dried (-)-pantoprazole preparation and (-)-pantoprazole injection
DE102004007854A1 (de) * 2004-02-17 2005-09-01 Hexal Ag Stabile, wässrige Formulierung für Benzimidazole
US20060085924A1 (en) * 2004-10-13 2006-04-27 Gaelle Brun Coloring composition comprising at least one pigment and at least one electrophilic cyanoacrylate monomer
CN1293879C (zh) * 2005-01-20 2007-01-10 杭州华东医药集团生物工程研究所有限公司 泮托拉唑钠冻干粉针剂及其制备方法
CA2624179A1 (en) * 2005-10-06 2007-04-12 Auspex Pharmaceuticals, Inc. Deuterated inhibitors of gastric h+, k+-atpase with enhanced therapeutic properties
AR061155A1 (es) * 2006-06-01 2008-08-06 Combino Pharm Sl Preparaciones liofilizadas de pantoprazol sodico para inyeccion
BRPI0715113A2 (pt) 2006-07-26 2013-06-04 Sandoz Ag Sandoz Sa Sandoz Ltd formulaÇço de caspofungina
US7979200B2 (en) * 2006-11-20 2011-07-12 Lockheed Martin Corporation Managing an air-ground communications network with air traffic control information
EP2106788A1 (en) * 2008-04-04 2009-10-07 Ipsen Pharma Liquid and freeze dried formulations
CN101744777B (zh) * 2009-12-30 2012-09-26 北京四环科宝制药有限公司 奥美拉唑钠冻干粉针剂及制备方法和检测方法
CN101961309B (zh) * 2010-09-15 2012-06-27 河南辅仁怀庆堂制药有限公司 注射用泮托拉唑钠配制工艺
CN102000034B (zh) * 2010-10-13 2011-12-21 江苏奥赛康药业股份有限公司 一种供注射用的s-泮托拉唑钠组合物及其制备方法
CN102225063B (zh) * 2011-05-10 2012-10-10 江苏奥赛康药业股份有限公司 一种供注射用的泮托拉唑钠组合物
TR201108946A2 (tr) * 2011-09-12 2012-04-24 World Medicine İlaç Sanayi̇ Ve Ti̇caret Li̇mi̇ted Şi̇rketi̇ Dondurularak kurutulmuş atp, vitamin b kompleksi preparatı ve enjeksiyonu.
SG11201408511QA (en) * 2012-06-27 2015-01-29 Takeda Pharmaceutical Liquid preparations of amines and organic acids stabilized by salts
CN104000786A (zh) * 2013-02-25 2014-08-27 杭州赛利药物研究所有限公司 泮托拉唑钠冻干制剂及其制备方法
CN104414979A (zh) * 2013-08-21 2015-03-18 哈药集团三精制药股份有限公司 一种泮托拉唑钠冻干粉针剂及其制备方法
CN104019635B (zh) * 2014-06-19 2015-05-27 上海慈瑞医药科技有限公司 一种兰索拉唑原料药化合物及其干燥工艺
CN104055791A (zh) * 2014-07-10 2014-09-24 北京人福军威医药技术开发有限公司 西地碘治疗眼角结膜炎的用途
CN104055792A (zh) * 2014-07-10 2014-09-24 北京人福军威医药技术开发有限公司 西地碘治疗中耳炎的用途
BE1021311B1 (nl) * 2014-07-31 2015-10-28 Neogen N.V. Werkwijze voor het maken van een poedervormige protonpompremmer samenstelling, genoemde samenstelling en gebruik
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
CN111643460A (zh) * 2020-06-30 2020-09-11 武汉九州钰民医药科技有限公司 泮托拉唑钠冻干制剂及其制备方法、由其制得的注射制剂
CN112274481A (zh) * 2020-10-27 2021-01-29 海南卫康制药(潜山)有限公司 一种注射用泮托拉唑钠组合物及其制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8301182D0 (sv) 1983-03-04 1983-03-04 Haessle Ab Novel compounds
IL75400A (en) 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
US5223515A (en) 1988-08-18 1993-06-29 Takeda Chemical Industries, Ltd. Injectable solution containing a pyridyl methylsulfinylbenzimidazole
DK399389A (da) 1988-08-18 1990-02-19 Takeda Chemical Industries Ltd Injicerbare oploesninger
DE4035455A1 (de) 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab Enantiomerentrennung
HU226778B1 (en) 1992-07-28 2009-10-28 Astra Ab Injection and injection kit containing omeprazole and its analogs
AU6713194A (en) 1993-04-27 1994-11-21 Sepracor, Inc. Methods and compositions for treating gastric disorders using optically pure (-) pantoprazole
DE4324014C2 (de) 1993-07-17 1995-06-08 Byk Gulden Lomberg Chem Fab Verfahren zur Herstellung einer in Wasser rekonstituierbaren Zubereitung
TW280770B (pl) 1993-10-15 1996-07-11 Takeda Pharm Industry Co Ltd
HU224987B1 (en) 1995-11-03 2006-05-29 Sanofi Aventis Stable freeze-dried pharmaceutical formulation
FR2740686B1 (fr) 1995-11-03 1998-01-16 Sanofi Sa Formulation pharmaceutique lyophilisee stable
US5980882A (en) * 1997-04-16 1999-11-09 Medeva Pharmaceuticals Manufacturing Drug-resin complexes stabilized by chelating agents
PT1039905E (pt) 1997-10-14 2006-11-30 Eisai Co Ltd Formulação farmacêutica que compreende glicina como um estabilizador
DE19843413C1 (de) * 1998-08-18 2000-03-30 Byk Gulden Lomberg Chem Fab Neue Salzform von Pantoprazol
WO2000026185A2 (en) 1998-10-30 2000-05-11 The Curators Of The University Of Missouri Omeprazole solution and method of using same
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
CN1235018A (zh) * 1999-04-22 1999-11-17 沈阳东宇药业有限公司 泮托拉唑钠冻干粉针剂及制备方法
SE9903831D0 (sv) 1999-10-22 1999-10-22 Astra Ab Formulation of substituted benzimidazoles
US7396841B2 (en) * 2000-08-18 2008-07-08 Takeda Pharmaceutical Company Limited Injections
MY137726A (en) * 2000-11-22 2009-03-31 Nycomed Gmbh Freeze-dried pantoprazole preparation and pantoprazole injection
AR045258A1 (es) 2003-08-21 2005-10-19 Altana Pharma Ag Un producto farmaceutico para inyeccion

Also Published As

Publication number Publication date
US7351723B2 (en) 2008-04-01
ME00556A (en) 2011-12-20
DE60132108D1 (de) 2008-02-07
NO20032303D0 (no) 2003-05-21
HUP0303278A2 (hu) 2004-01-28
SI1339430T1 (sl) 2008-06-30
ZA200303593B (en) 2004-04-23
IS6820A (is) 2003-05-19
YU37703A (sh) 2006-05-25
KR20030055308A (ko) 2003-07-02
MY137726A (en) 2009-03-31
KR100910606B1 (ko) 2009-08-04
PT1339430E (pt) 2008-03-27
BG107828A (bg) 2004-07-30
ATE381946T1 (de) 2008-01-15
BRPI0115483B1 (pt) 2017-05-09
ES2298295T3 (es) 2008-05-16
CA2541946A1 (en) 2002-05-30
IL155601A0 (en) 2003-11-23
GEP20053461B (en) 2005-02-25
BRPI0115483B8 (pt) 2021-05-25
HUP0303278A3 (en) 2007-08-28
PL201188B1 (pl) 2009-03-31
EE200300182A (et) 2003-06-16
EA007602B1 (ru) 2006-12-29
SK6062003A3 (en) 2003-10-07
NO20032303L (no) 2003-05-21
KR100910607B1 (ko) 2009-08-04
EP1339430B1 (en) 2007-12-26
RS52024B (sr) 2012-04-30
PE20020582A1 (es) 2002-07-06
EA200300501A1 (ru) 2003-12-25
SK287993B6 (sk) 2012-09-03
HRP20030410B1 (en) 2011-02-28
EE05236B1 (et) 2009-12-15
NZ525911A (en) 2004-11-26
DK1339430T3 (da) 2008-05-13
AU2002216042B2 (en) 2006-08-03
IL155601A (en) 2008-12-29
US20090093522A1 (en) 2009-04-09
HK1060848A1 (en) 2004-08-27
KR20080003010A (ko) 2008-01-04
TWI284041B (en) 2007-07-21
WO2002041919A1 (en) 2002-05-30
EP1762249A3 (en) 2014-05-14
BR0115483A (pt) 2003-10-21
US8754108B2 (en) 2014-06-17
AR092374A2 (es) 2015-04-15
ECSP034613A (es) 2003-08-29
EP1339430A1 (en) 2003-09-03
BG66329B1 (bg) 2013-06-28
CY1107896T1 (el) 2013-09-04
MXPA03004548A (es) 2003-09-10
DE60132108T2 (de) 2008-12-11
JP2004513970A (ja) 2004-05-13
IS2971B (is) 2017-05-15
US20040220228A1 (en) 2004-11-04
CZ20031416A3 (cs) 2003-09-17
ME00556B (me) 2011-12-20
NO332937B1 (no) 2013-02-04
CA2428870A1 (en) 2002-05-30
AU1604202A (en) 2002-06-03
CA2428870C (en) 2006-05-23
HRP20030410A2 (en) 2005-04-30
EP1762249A2 (en) 2007-03-14
CZ304348B6 (cs) 2014-03-19
AR034277A1 (es) 2004-02-18
CN1250292C (zh) 2006-04-12
US6780881B2 (en) 2004-08-24
CN1476335A (zh) 2004-02-18
UA80961C2 (en) 2007-11-26
JP4886158B2 (ja) 2012-02-29
US20030003058A1 (en) 2003-01-02

Similar Documents

Publication Publication Date Title
AU1604202A (en) Freeze-dried pantoprazole preparation and pantoprazole injection
EG23122A (en) Pyrrolcarboxamides and pyrrolcarbothioamides
AU9667901A (en) Mycoattractants and mycopesticides
IL151465A0 (en) Miniaturized needleless injector
EP1282447A4 (en) STABLE POLYMER MICRICO-TYPE DRUG PREPARATION AND METHOD FOR THE PRODUCTION THEREOF
MXPA02009082A (es) Conjugados de acido poliglutamico-camptotecina y metodos de preparacion.
AU2002227414A8 (en) Infusion devices and method
HUP0301076A3 (en) Linezolid-crystal form ii and preparation thereof
HK1047060B (zh) 可移動的分段式塊體玩具
IL148247A (en) Vaccine and its uses
AU5695701A (en) Salmonella vaccine materials and methods
SG90258A1 (en) Solid state imager having gated photodiodes and method for making same
AU9567201A (en) Vaccine composition and stabilisation method
GB2358988B (en) Feature implementation and provisioning by injection
AU2002221759A1 (en) Polypeptides and polynucleodides from haemophilus influenzae and their use
GB0027720D0 (en) Games and toys
GB2398787B (en) Organic anti-reflective polymer and preparation thereof
EG24100A (en) Once used injector
TW459754U (en) Improved storage structure for necktie and ornaments thereof
GB0022753D0 (en) Polymers their preparation and uses
GB0000095D0 (en) Polymers their preparation and uses
GB0029496D0 (en) Optipouch and optipad
GB0008876D0 (en) IC2CU and IC2IDU
SI1263490T1 (sl) Brezigelni injektor v miniaturni izvedbi
GB0121553D0 (en) Edging-slabs and methods using them